To investigate the underlying mechanism, we referred to a study by Parpart et al., revealing transcription factor c-Myc activation in HCC patients with high AFP levels [18], indicating a potential role of c-Myc in AFP-expressing tumors. Here, MYC is linked to hepatocellular carcinoma.